Optimal isolation control strategies and cost-effectiveness analysis of a two-strain avian influenza model

BioSystems

Volumn 113, Issue 3, 2013, Pages 155-164

  Agusto, F B ^a  

^a AUSTIN PEAY STATE UNIVERSITY   (United States)

Author keywords

Avian influenza; Incremental cost effectiveness ratio; Infection averted ratio; Isolation; Mutation; Optimal control

Indexed keywords

AVIAN INFLUENZA; COST-BENEFIT ANALYSIS; DISEASE CONTROL; EPIDEMIC; MUTATION; OPTIMIZATION; VACCINE; VIRUS;

ARTICLE; AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; CONTROL STRATEGY; COST EFFECTIVENESS ANALYSIS; DISEASE MODEL; DISEASE SIMULATION; DISEASE TRANSMISSION; HUMAN; INFECTION CONTROL; NONHUMAN;

AVES;

92B05; 93A30; 93C15; AVIAN INFLUENZA; INCREMENTAL COST-EFFECTIVENESS RATIO; INFECTION AVERTED RATIO; ISOLATION; MUTATION; OPTIMAL CONTROL;

ANIMALS; BIRDS; COST-BENEFIT ANALYSIS; DISEASE OUTBREAKS; HUMANS; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MODELS, ECONOMIC;

EID: 84880989327     PISSN: 03032647     EISSN: 18728324     Source Type: Journal    
DOI: 10.1016/j.biosystems.2013.06.004     Document Type: Article

References (45)

1. Agusto F.B., Gumel A.B. Quantitative analysis for a model for the transmission dynamics of low and highly pathogenic avian influenza. J. Math. Biosci. 2013, 243(2):147-162.
2. Agusto F.B., Lenhart S. Optimal control of the spread of malaria super-infectivity. J. Biol. Syst. 2013, (Special issue on Infectious Disease Modeling, in press).
3. Agusto F.B., Marcus N., Okosun K.O. Application of optimal control to the epidemiology of malaria disease. Electron. J. Differential Equations 2012, 2012(81):1-22.
4. Agusto F.B., Gumel A.B. Theoretical assessment of avian influenza vaccine. DCDS Ser. B 2010, 13(1):1-25. 10.3934/dcdsb.2009.13.1.
5. Agusto F.B., Ogunye O.R. Avian influenza optimal seasonal vaccination therapy. AZIAM J. 2010, 51:394-405.
6. Agusto F.B. Optimal chemoprophylaxis control strategies of a tuberculosis transmission model. World J. Model. Simulation 2009, 5(3):163-173.
7. Beigel J.H., et al. Avian influenza A (H5N1) infection in humans?. N. Engl. J. Med. 2005, 353(13):1374-1385.
8. Bowman C., Gumel A.B., van den Driessche P., Wu J., Zhu H. A mathematical model for assessing control strategies against West Nile virus. Bull. Math. Biol. 2005, 67:1107-1133.
9. Butler D. Disease surveillance needs a revolution. Nature 2006, 440(7080):6-7.
10. Cantor S.B., Ganiats T.G. Incremental cost-effectiveness analysis: the optimal strategy depends on the strategy set. Clin. Epidemiol. 1999, 52(6):517-522.
11. Chowell G., et al. Model parameters and outbreak control for SARS. Emerg. Infect. Dis. 2004, 10(7):1258-1263.
12. Chowell G., Fenimore P.W., Castillo-Garsow M.A., Castillo-Chavez C. SARS outbreaks in Ontario, Hong Kong and Singapore: the role of diagnosis and isolation as a control mechanism. J. Theor. Biol. 2003, 224:1-8.
13. Ferguson N.M., et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 2005, 437(7056):209-214.
14. Fiscella K., Franks P. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling. JAMA 1996, 276:1247-1251.
15. Fleming W.H., Rishel R.W. Deterministic and Stochastic Optimal Control 1975, Springer Verlag, New York.
16. Freedberg K.A., Scharfstein J.A., Seage G.R., Losina E., Weinstein M.C., Craven D.E., et al. The cost-effectiveness of preventing AIDS-related opportunistic infections. JAMA 1998, 279:130-136.
17. Gani R., et al. Potential impact of antiviral drug use during influenza pandemic. Emerg. Infect. Dis. 2005, 11(9):1355-1362.
18. Germann T.C., et al. Mitigation strategies for pandemic influenza in the United States. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(15):5935-5940.
19. Gumel A.B., Nuno M., Chowell G. Mathematical assessment of Canada's pandemic influenza preparedness plan. Can. J. Infect. Dis. Med. Microbiol. 2008, 19:185-192.
20. Gumel A.B., et al. Modelling strategies for controlling SARS outbreaks. Proc. R. Soc. Lond. B 2004, 2223-2232.
21. Gumel A.B. Global dynamics of a two-strain avian influenza model?. Int. J. Comput. Math. 2009, 86(1):85-108.
22. Hethcote H.W. The mathematics of infectious diseases. SIAM Rev. 2000, 42(4):599-653.
23. Iwami S., Takeuchi Y., Liu X. Avian-human influenza epidemic model. Math. Biosci. 2007, 207(1):1-25.
24. Jung E., Iwami S., Takeuchi Y., Jo T. Optimal control strategy for prevention of Avian-human influenza pandemic. J. Theor. Biol. 2009, 260:220-229.
25. Joshi H.R. Optimal control of an HIV immunology model. Optim. Control Appl. Math. 2002, 23:199-213.
26. Jung E., Lenhart S., Feng Z. Optimal control of treatments in a two-strain tuberculosis model. Discrete Continuous Dynamical Syst. Ser. B 2002, 2(4):473-482.
27. Kern D., Lenhart S., Miller R., Yong J. Optimal control applied to native-invasive population dynamics. J. Biol. Dyn. 2007, 1(4):413-426. 10.1080/17513750701605556.
28. Kirschner D., Lenhart S., Serbin S. Optimal control of the chemotherapy of HIV. J. Math. Biol. 1997, 35:775-792.
29. Lenhart S., Workman J.T. Optimal Control Applied to Biological Models 2007, Chapman and Hall.
30. Longini I.M., et al. Containing the pandemic influenza with antiviral agents. Am. J. Epidemiol. 2004, 159(7):623-633.
31. Longini I.M., Halloran M.E. Strategy for distribution of influenza vaccine to high-risk groups and children. Am. J. Epidemiol. 2005, 161(4):303-306.
32. Lukes D.L. Differential Equations: Classical to Controlled, Mathematics in Science and Engineering 1982, Academic Press, New York.
33. Menach A.L., Vergu E., Grais R.F., Smith D.L., Flahault A. Key strategies for reducing spread of avian influenza among commercial poultry holdings: lessons for transmission to humans. Proc. R. Soc. Lond. B 2006, 273:2467-2475.
34. Mills C.E., Robins J.M., Lipsitch M. Transmissibility of 1918 pandemic influenza. Nature 2004, 432(7019):904-906.
35. Nuño M., Chowell G., Gumel A.B. Assessing the role of basic control measures, antivirals and vaccine in curtailing pandemic influenza: scenarios for the US, UK and the Netherlands. J. R. Soc. Interface. 2007, 4:505-521.
36. Nuño M., Reichert T.A., Chowell G., Gumel A.B. Protecting residential care facilities from pandemic influenza. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(30):10625-10630.
37. Okosun K.O., Rachid O., Marcus N. Optimal control strategies and cost-effectiveness analysis of a malaria model. Biosystems 2013, 111(2):83-101.
38. Pinkerton S.D., Holtgrave D.R., DiFranceisco W.J., Stevenson L.Y., Kelly J.A. Cost-effectiveness of a community-level HIV risk reduction intervention. Am. J. Public Health 1998, 88:1239-1242.
39. Podder C.N., Gumel A.B., Bowman C.S., Mcleod R.G. Mathematical study of the impact of quarantine, isolation and vaccination in curtailing an epidemic. J. Biol. Syst. 2007, 15:2:185-202.
40. Pontryagin L.S., Boltyanskii V.G., Gamkrelidze R.V., Mishchenko E.F. The Mathematical Theory of Optimal Processes 1962, Wiley, New York.
41. Rvachev L.A., Longini I.M. A mathematical model for the global spread of influenza. Math. Biosci. 1985, 75:3-22.
42. van Genugten M.L., Heijnen M.L., Jager J.C. Pandemic influenza and healthcare demand in the Netherlands. Scenario analysis. Emerg. Infect. Dis. 2003, 9(5):531-538.
43. WHO Influenza Pandemic Risk Assessment and Preparedness in Africa 2005, (accessed 11.10.08).
44. Yan X., Zou Y., Li J. Optimal quarantine and isolation strategies in epidemics control. World J. Model. Simulation 2007, 33:202-211.
45. Yan X., Zou Y. Optimal and sub-optimal quarantine and isolation control in SARS epidemics. Math. Comput. Model. 2008, 47:235-2453.